Salihu (Oyiza) Asimawu: What If Blood Could Be Prepared in the Lab?
Salihu (Oyiza) Asimawu, Medical Laboratory Science Student and Research and Innovation Enthusiast at Ahmadu Bello University, shared a post on LinkedIn:
”What if blood could be prepared in the lab?
During my hematology lab posting at the cross-matching bench, I witnessed a situation that made me reflect deeply on innovation in healthcare. A patient required blood, but there was no exact match available in the blood bank. O-negative was in stock, yet the lab manager hesitated to release it immediately, as it is rare and may be urgently needed for another patient.
That moment sparked a discussion between a colleague and me: What if blood could be produced in the laboratory? What if bioengineered blood could reduce the constant pressure around scarce blood groups like O-negative?
We went on to ask a scientist about the possibility. He explained that while fully functional, clinically available lab-produced blood is not yet widely established, researchers have developed experimental red blood cells and oxygen-carrying substitutes that can mimic certain supplementary functions of blood.
Exploring further, I learned that although bioengineered blood vessels and some blood substitutes have been developed, fully functional lab-produced blood remains largely theoretical. Blood is not just red cells—it includes plasma, platelets, clotting factors, antibodies, and precise ABO/Rh antigens. Replicating all these components accurately makes it an incredibly complex scientific challenge.
This experience highlighted the vast potential for research and innovation in transfusion medicine and diagnostics. It strengthened my curiosity about contributing to solutions that could improve patient care and healthcare accessibility.”

Stay updated with Hemostasis Today.
-
Jul 14, 2026, 19:35Daratumumab in Difficult-to-Treat iTTP: Updated Results from the International DarTTP Study
-
Jul 14, 2026, 17:1610 Posts Not To Miss from ISTH 2026, Part 3
-
Jul 14, 2026, 15:27Dianne E Van Der Wal: Celebrating Scientific Contributions at ISTH 2026
-
Jul 14, 2026, 15:13Alfonso Tafur: RIETE Registry Analysis Supports More Equitable Approaches to VTE Care
-
Jul 14, 2026, 15:03Heghine Khachatryan: Phase III Trial Results Support BAFF-R Inhibition in Corticosteroid-Refractory ITP
-
Jul 14, 2026, 14:51Nathan Connell: ISTH 2026 Highlights the Power of Lifelong Collaboration
-
Jul 14, 2026, 14:42Wolfgang Miesbach: VOYAGER1 Highlights Progress Toward Injection-Free Care in Hemophilia A
-
Jul 14, 2026, 12:08Elvira Grandone: Finding the Right LMWH Dose for Pregnant Patients Suffering From DVT
-
Jul 14, 2026, 12:05Eloïse Laouenan: From Washington to Paris – Join GETBO at ISTH 2026